Jove
Visualize
Contact Us

Related Experiment Videos

Sample size re-estimation in group-sequential response-adaptive clinical trials.

Caroline C Morgan1

  • 1Cardinal Systems, 91, avenue de la République, Paris 75011, France. c.morgan@cardinal-sys.com

Statistics in Medicine
|December 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, controlled trial of oral propranolol in infantile hemangioma.

The New England journal of medicine·2015
Same author

An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.

Statistics in medicine·2011
Same author

Population pharmacokinetics of artesunate and amodiaquine in African children.

Malaria journal·2009
Same author

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.

Malaria journal·2009
Same author

A comparison of adaptive allocation rules for group-sequential binary response clinical trials.

Statistics in medicine·2006
Same author

Estimation following group-sequential response-adaptive clinical trials.

Controlled clinical trials·2003
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Accurate sample size re-estimation in clinical trials is crucial for maintaining desired statistical power. This study introduces a new group-sequential response-adaptive design that updates sample size estimates at interim analyses, improving error rate control.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methods

Background:

  • Inaccurate variance estimates in clinical trials can significantly impact Type II error rates.
  • Sample size re-estimation methods, originating from Stein's two-stage procedure, aim to improve accuracy by utilizing interim data.
  • Existing methods for fixed and sequential trials need extension for complex adaptive designs.

Purpose of the Study:

  • To review and extend existing sample size re-estimation methods for group-sequential response-adaptive designs.
  • To present a novel test for a group-sequential response-adaptive design comparing two treatments with unknown variances.
  • To assess the performance of the new test in maintaining nominal error rates and power.

Main Methods:

  • Review of existing sample size re-estimation techniques for fixed and sequential clinical trials.

Related Experiment Videos

  • Extension of these methods to group-sequential response-adaptive designs.
  • Development and simulation of a modified Stein's test incorporating updated sample size calculations and variance estimates at each interim analysis.

    • Main Results:

    • The proposed modified Stein's test demonstrated a Type I error rate close to the nominal value.
    • The new test more accurately maintained the desired statistical power compared to existing methods.
    • Updating sample size and using current variance estimates at each stage utilizes all available information effectively.

    Conclusions:

    • The novel group-sequential response-adaptive design with interim sample size updating effectively controls Type I and Type II errors.
    • This approach offers improved accuracy in maintaining statistical power in clinical trials with unknown variances.
    • The modified Stein's test provides a robust method for adaptive clinical trial designs.